Edition:
United States

Oxford BioMedica PLC (OXB.L)

OXB.L on London Stock Exchange

1,003.80GBp
22 Jun 2018
Change (% chg)

-46.20 (-4.40%)
Prev Close
1,050.00
Open
1,039.20
Day's High
1,057.60
Day's Low
986.00
Volume
608,053
Avg. Vol
211,293
52-wk High
1,064.38
52-wk Low
265.00

Latest Key Developments (Source: Significant Developments)

Patrick Machado Says Axovant Sciences Agreed To Sell To Roivant 14.3 Mln Shares
Thursday, 7 Jun 2018 07:54am EDT 

June 7 (Reuters) - Patrick Machado::PATRICK MACHADO SAYS ON JUNE 5, ROIVANT ENTERED SHARE PURCHASE AGREEMENT - SEC FILING.PATRICK MACHADO SAYS AXOVANT SCIENCES AGREED TO ISSUE, SELL TO ROIVANT 14.3 MILLION SHARES AT $1.75/ SHARE IN A PRIVATE PLACEMENT.PATRICK MACHADO SAYS ROIVANT PROVIDED FINANCING WITH AXOVANT'S ENTRY TO LICENSE AGREEMENT WITH OXFORD BIOMEDICA.PATRICK MACHADO - ROIVANT REMAINS DIRECT OWNER OF 89.3 MILLION SHARES OF AXOVANT, INCLUDING 75 MILLION SHARES BENEFICIALLY OWNED BEFORE AXOVANT’S IPO.PATRICK MACHADO SAYS SHARES DISPOSITIVE POWER OVER ROIVANT’S 89.3 MILLION SHARES OF AXOVANT WITH OTHER INDEPENDENT DIRECTOR OF ROIVANT CURRENTLY SERVING.  Full Article

Oxford Biomedica Announces ‍Proposed Placing To Raise About 20.5 Mln STG
Friday, 9 Mar 2018 10:17am EST 

March 9 (Reuters) - Oxford Biomedica Plc ::OXFORD BIOMEDICA PLC - ‍PROPOSED PLACING TO RAISE APPROXIMATELY £20.5 MILLION​.OXFORD BIOMEDICA - TO RAISE ABOUT £20.5 MILLION BY WAY OF CONDITIONAL PLACING OF UP TO 174.3 MILLION NEW SHARES AT A PRICE OF 11.75 PENCE PER PLACING SHARE​.OXFORD BIOMEDICA PLC - PLACING ‍TO FUND EXPANSION OF ITS BIOPROCESSING FACILITIES​.  Full Article

Oxford Biomedica Says ‍Kymriah Receives Priority Review For Adult DLBCL​
Wednesday, 17 Jan 2018 02:00am EST 

Jan 17 (Reuters) - Oxford Biomedica Plc ::SAYS ‍KYMRIAH RECEIVES PRIORITY REVIEW FOR ADULT DLBCL​.  Full Article

Oxford Biomedica says Stuart Paynter joins group as CFO
Tuesday, 29 Aug 2017 02:00am EDT 

Aug 29 (Reuters) - Oxford Biomedica Plc :STUART PAYNTER TODAY JOINS GROUP AS CHIEF FINANCIAL OFFICER AND MEMBER OF BOARD OF DIRECTORS.TIM WATTS, OUTGOING CFO WILL REMAIN UNTIL 29 SEPTEMBER 2017 AT WHICH POINT HE WILL STEP DOWN FROM BOARD AND LEAVE GROUP.  Full Article

Oxford Biomedica completes new $55 million debt facility
Friday, 30 Jun 2017 05:38am EDT 

June 30 (Reuters) - Oxford Biomedica Plc ::Completed a new $55 million debt facility with Oaktree Capital Management - Strategic Credit Strategy.Facility has been used to redeem existing debt facility with Oberland Capital Healthcare.  Full Article

Oxford Biomedica notes acceptance by FDA of a biologics license application filing for CTL019
Thursday, 30 Mar 2017 02:02am EDT 

Oxford Biomedica Plc : Oxford Biomedica notes acceptance by FDA of a biologics license application (BLA) filing for CTL019 .Oxford Biomedica will also receive undisclosed royalties on potential future sales of Novartis Car-T products..  Full Article

Oxford biomedica says FY EBITDA loss reduced to £7.1 mln
Thursday, 16 Mar 2017 03:13am EDT 

Oxford Biomedica Plc : Fy EBITDA loss reduced to £7.1 million .Fy gross income increased by 64% to £30.8 million.  Full Article

Oxford biomedica says Trovax shown to induce beneficial anti-tumour immune responses
Friday, 24 Feb 2017 02:28am EST 

Oxford Biomedica Plc : Cyclophosphamide and Trovax independently shown to induce highly beneficial anti-tumour immune responses .Both drugs resulting in significantly prolonged survival of advanced colorectal cancer patients.  Full Article

BRIEF-Oxford Biomedica Announces ‍Proposed Placing To Raise About 20.5 Mln STG

* OXFORD BIOMEDICA PLC - ‍PROPOSED PLACING TO RAISE APPROXIMATELY £20.5 MILLION​